Literature DB >> 24571608

Optic and auditory pathway dysfunction in demyelinating neuropathies.

M Knopp1, R J Leese, D Martin-Lamb, Y A Rajabally.   

Abstract

OBJECTIVE: The involvement of optic and auditory pathways has rarely been studied in demyelinating polyneuropathies. We here aimed to study this further in a cohort of patients with acquired and gentic demyelinating neuropathy.
METHODS: We studied eight patients with hereditary neuropathy with liability to pressure palsies (HNPP), six with Charcot-Marie-Tooth disease type 1A (CMT1A), ten with chronic inflammatory demyelinating polyneuropathy (CIDP) and seven with antimyelin-associated glycoprotein (MAG) neuropathy using visual evoked potentials and brainstem auditory evoked potentials.
RESULTS: Optic pathway dysfunction was detected in 6/7 anti-MAG neuropathy patients, about half of those with CIDP and HNPP, but only in 1/6 patients with CMT1A. Peripheral auditory nerve dysfunction appeared common in all groups except HNPP. Brainstem involvement was exceptional in all groups.
CONCLUSIONS: We conclude optic nerve involvement may be frequent in all demyelinating polyneuropathies, particularly anti-MAG neuropathy, except in CMT1A. Peripheral auditory nerves may be spared in HNPP possibly due to absence of local compression. Evidence for central brainstem pathology appeared infrequent in all four studied neuropathies. This study suggests that acquired and genetic demyelinating polyneuropathies may be associated with optic and auditory nerve involvement, which may contribute to neurological disability, and require greater awareness.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BAEP; CIDP; CMT1A; HNPP; VEP; anti-MAG; auditory; cranial; neuropathy; optic

Mesh:

Year:  2014        PMID: 24571608     DOI: 10.1111/ane.12226

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Chronic inflammatory demyelinating polyneuropathy: evaluation of the vestibular system with cervical and ocular vestibular evoked myogenic potentials.

Authors:  Giuseppe Magliulo; Giannicola Iannella; Alessandra Manno; Laura Libonati; Emanuela Onesti; Annarita Vestri; Danilo Alunni Fegatelli; Diletta Angeletti; Annalisa Pace; Giampiero Gulotta; Silvia Gagliardi; Maurizio Inghilleri
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-27       Impact factor: 2.503

2.  PMP22 Gene-Associated Neuropathies: Phenotypic Spectrum in a Cohort from India.

Authors:  Madhu Nagappa; Shivani Sharma; Periyasamy Govindaraj; Yasha T Chickabasaviah; Ramesh Siram; Akhilesh Shroti; Monojit Debnath; Sanjib Sinha; Parayil S Bindu; Arun B Taly
Journal:  J Mol Neurosci       Date:  2020-01-28       Impact factor: 3.444

3.  Characterization of Charcot-Marie-Tooth optic neuropathy.

Authors:  Benjamin Botsford; Laurel N Vuong; Thomas R Hedges; Carlos E Mendoza-Santiesteban
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

4.  Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.

Authors:  Alexander U Brandt; Elena Meinert-Bohn; Jan Leo Rinnenthal; Hanna Zimmermann; Janine Mikolajczak; Timm Oberwahrenbrock; Sebastian Papazoglou; Caspar F Pfüller; Johann Schinzel; Björn Tackenberg; Friedemann Paul; Katrin Hahn; Judith Bellmann-Strobl
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

5.  Multifocal visual evoked potentials in chronic inflammatory demyelinating polyneuropathy.

Authors:  Jonas Graf; Lea Jansen; Jens Ingwersen; Marius Ringelstein; Jens Harmel; Jana Rybak; Robert Kolbe; Laura Rhöse; Lena Gemerzki; John-Ih Lee; Alexander Klistorner; Rainer Guthoff; Hans-Peter Hartung; Orhan Aktas; Philipp Albrecht
Journal:  Ann Clin Transl Neurol       Date:  2018-07-07       Impact factor: 4.511

6.  Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome.

Authors:  Alice Verghese; Dhayalan Krishnan; Yuen Kang Chia; Luis Querol; Fu Liong Hiew
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-06

7.  CNS Involvement in Chronic Inflammatory Demyelinating Polyneuropathy: Subtle Retinal Changes in Optical Coherence Tomography.

Authors:  Jens Ingwersen; Jonas Graf; Julia Kluge; Margit Weise; Michael Dietrich; John-Ih Lee; Jens Harmel; Hans-Peter Hartung; Tobias Ruck; Sven G Meuth; Philipp Albrecht; Orhan Aktas; Marius Ringelstein
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-19

8.  Multifocal motor neuropathy and visual pathway impairment: A case report.

Authors:  Keisuke Kido; Shinichi Wada; Yuwa Oka; Yuta Terada; Manabu Inoue; Toshiaki Hamano
Journal:  Clin Neurophysiol Pract       Date:  2021-06-16

Review 9.  Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.

Authors:  Jun-Ichi Kira
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.